Quantbot Technologies LP Enanta Pharmaceuticals Inc Transaction History

Quantbot Technologies LP

$2.36 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$10.08 - $17.46 $46,368 - $80,316	-4,600 Reduced 92.0%	400 $6,000
Q4 2023 Feb 14, 2024	SELL	$8.18 - $10.78 $17,996 - $23,716	-2,200 Reduced 30.56%	5,000 $47,000
Q3 2023 Nov 07, 2023	BUY	$11.09 - $22.13 $76,521 - $152,697	6,900 Added 2300.0%	7,200 $80,000
Q2 2023 Aug 08, 2023	BUY	$20.68 - $39.85 $6,204 - $11,955	300 New	300 $6,000
Q3 2022 Nov 07, 2022	SELL	$48.29 - $71.27 $109,038 - $160,927	-2,258 Reduced 98.3%	39 $2,000
Q2 2022 Aug 09, 2022	BUY	$38.13 - $76.93 $86,936 - $175,400	2,280 Added 13411.76%	2,297 $108,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $285,906 - $377,961	-5,100 Reduced 99.67%	17 $1,000
Q4 2021 Feb 11, 2022	BUY	$60.19 - $97.37 $307,992 - $498,242	5,117 New	5,117 $382,000
Q1 2021 May 14, 2021	SELL	$41.69 - $54.95 $4,294 - $5,659	-103 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$41.16 - $47.47 $4,239 - $4,889	103 New	103 $4,000
Q1 2020 May 13, 2020	SELL	$40.22 - $62.0 $121,263 - $186,930	-3,015 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$57.95 - $66.61 $150,090 - $172,519	2,590 Added 609.41%	3,015 $186,000
Q3 2019 Nov 12, 2019	SELL	$60.08 - $88.17 $19,946 - $29,272	-332 Reduced 43.86%	425 $25,000
Q2 2019 Aug 13, 2019	BUY	$81.3 - $97.35 $61,544 - $73,693	757 New	757 $63,000
Q4 2018 Feb 13, 2019	SELL	$65.41 - $84.65 $76,529 - $99,040	-1,170 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $99,988 - $147,852	1,170 New	1,170 $99,000
Q2 2018 Aug 13, 2018	SELL	$81.85 - $120.51 $593,903 - $874,420	-7,256 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$57.91 - $92.15 $420,194 - $668,640	7,256 New	7,256 $587,000
Q4 2017 Feb 12, 2018	SELL	$45.65 - $59.37 $96,321 - $125,270	-2,110 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$37.91 - $46.8 $79,990 - $98,748	2,110	2,110 $98,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.

Account